41 related articles for article (PubMed ID: 12738731)
1. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
Shigemasa K; Gu L; O'Brien TJ; Ohama K
Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to "Amentoflavone suppresses tumor growth in ovarian cancer by modulating Skp2" [Life Sci. 189 (2017) 96-105].
Liu H; Yue Q; He S
Life Sci; 2024 May; 344():122585. PubMed ID: 38521621
[No Abstract] [Full Text] [Related]
3. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review.
Jing J; Rui L; Junyuan S; Jinfeng Y; Zhihao H; Weiguo L; Zhenyu J
Front Pharmacol; 2023; 14():1122008. PubMed ID: 37089937
[TBL] [Abstract][Full Text] [Related]
5. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
[TBL] [Abstract][Full Text] [Related]
6. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
7. Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.
Zheng S; Fu Y
Transl Oncol; 2020 Dec; 13(12):100863. PubMed ID: 32898767
[TBL] [Abstract][Full Text] [Related]
8. Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcoma.
Wang J; Sato K; O'Donnell E; Singla A; Yaguare S; Aldahamsheh O; Batko B; Borjihan H; Tingling J; Zhang J; Weiser DA; Loeb DM; Gorlick R; Schwartz EL; Yang R; Zi X; Zhao H; Geller DS; Hoang BH
Transl Oncol; 2020 Oct; 13(10):100809. PubMed ID: 32623326
[TBL] [Abstract][Full Text] [Related]
9. F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.
Tekcham DS; Chen D; Liu Y; Ling T; Zhang Y; Chen H; Wang W; Otkur W; Qi H; Xia T; Liu X; Piao HL; Liu H
Theranostics; 2020; 10(9):4150-4167. PubMed ID: 32226545
[TBL] [Abstract][Full Text] [Related]
10. The Skp2 Pathway: A Critical Target for Cancer Therapy.
Cai Z; Moten A; Peng D; Hsu CC; Pan BS; Manne R; Li HY; Lin HK
Semin Cancer Biol; 2020 Dec; 67(Pt 2):16-33. PubMed ID: 32014608
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.
Jung D; Khurana A; Roy D; Kalogera E; Bakkum-Gamez J; Chien J; Shridhar V
Sci Rep; 2018 Feb; 8(1):2487. PubMed ID: 29410485
[TBL] [Abstract][Full Text] [Related]
12. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C
J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430
[TBL] [Abstract][Full Text] [Related]
13. Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells.
Mou H; Guo P; Li X; Zhang C; Jiang J; Wang L; Wang Q; Yuan Z
Cell Cycle; 2017 Jul; 16(14):1366-1375. PubMed ID: 28594256
[TBL] [Abstract][Full Text] [Related]
14. FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.
De La Chesnaye E; Méndez JP; López-Romero R; De Los Angeles Romero-Tlalolini M; Vergara MD; Salcedo M; Ojeda SR
Int J Clin Exp Pathol; 2015; 8(9):10192-203. PubMed ID: 26617728
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) by Akt promotes stability and mitogenic function of S-phase kinase-associated protein-2 (Skp2).
Song GJ; Leslie KL; Barrick S; Mamonova T; Fitzpatrick JM; Drombosky KW; Peyser N; Wang B; Pellegrini M; Bauer PM; Friedman PA; Mierke DF; Bisello A
J Biol Chem; 2015 Jan; 290(5):2879-87. PubMed ID: 25492869
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
Wang X; Ren Q; Wu T; Guo Y; Liang Y; Liu S
Mol Med Rep; 2014 Dec; 10(6):2917-23. PubMed ID: 25310357
[TBL] [Abstract][Full Text] [Related]
17. Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.
Gamwell LF; Gambaro K; Merziotis M; Crane C; Arcand SL; Bourada V; Davis C; Squire JA; Huntsman DG; Tonin PN; Vanderhyden BC
Orphanet J Rare Dis; 2013 Feb; 8():33. PubMed ID: 23433318
[TBL] [Abstract][Full Text] [Related]
18. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer.
Lu M; Zhao Y; Xu F; Wang Y; Xiang J; Chen D
Med Oncol; 2012 Dec; 29(5):3409-15. PubMed ID: 22714061
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic Signaling by the gep Oncogene Involves the Upregulation of S-Phase Kinase-Associated Protein 2.
Radhakrishnan R; Ha JH; Dhanasekaran DN
Genes Cancer; 2010 Oct; 1(10):1033-43. PubMed ID: 21533006
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
